Increased numbers of orexin/hypocretin neurons in a genetic rat depression model

Neuropeptides

Volumn 45, Issue 6, 2011, Pages 401-406

  Mikrouli, Elli ^a   Wörtwein, Gitta ^b,c   Soylu, Rana ^a   Mathé, Aleksander A ^d   Petersén, Åsa ^a  

^a LUND UNIVERSITY   (Sweden)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

CART; Depression; Flinders Sensitive Line rat; Hypothalamus; MCH; Orexin; SSRI

Indexed keywords

COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; ESCITALOPRAM; MELANIN CONCENTRATING HORMONE; OREXIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DEPRESSION; FEMALE; FORCED SWIMMING TEST; GENETIC MODEL; HYPOTHALAMUS; IMMOBILIZATION; METABOLIC DISORDER; NERVE CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RAT; RAT STRAIN; SLEEP DISORDER; STEREOLOGY;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BEHAVIOR, ANIMAL; BODY WEIGHT; CITALOPRAM; DEPRESSION; DISEASE MODELS, ANIMAL; ENERGY METABOLISM; FEMALE; HUMANS; HYPOTHALAMIC HORMONES; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MELANINS; NERVE TISSUE PROTEINS; NEURONS; NEUROPEPTIDES; NEUROPSYCHOLOGICAL TESTS; PITUITARY HORMONES; RATS; RATS, INBRED STRAINS;

ANIMALIA; RATTUS;

EID: 83355166842     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2011.07.010     Document Type: Article

References (45)

1. Allard J.S., Tizabi Y., Shaffery J.P., Manaye K. Effects of rapid eye movement sleep deprivation on hypocretin neurons in the hypothalamus of a rat model of depression. Neuropeptides 2007, 41:329-337.
2. Allard J.S., Tizabi Y., Shaffery J.P., Trouth C.O., Manaye K. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression. Neuropeptides 2004, 38:311-315.
3. Bao A.M., Meynen G., Swaab D.F. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res. Rev. 2008, 57:531-553.
4. Berton O., Nestler E.J. New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 2006, 7:137-151.
5. Bjørnebekk A., Mathé A.A., Brené S. The antidepressant effects of running and escitalopram are associated with levels of hippocampal NPY and Y1 receptor but not cell proliferation in a rat model of depression. Hippocampus 2010, 20:820-828.
6. Bjornebekk A., Mathe A.A., Gruber S.H., Brene S. Housing conditions modulate escitalopram effects on antidepressive-like behaviour and brain neurochemistry. Int. J. Neuropsychopharmacol. 2008, 11:1135-1147.
7. Borowsky B., Durkin M.M., Ogozalek K., Marzabadi M.R., DeLeon J., Lagu B., Heurich R., Lichtblau H., Shaposhnik Z., Daniewska I., Blackburn T.P., Branchek T.A., Gerald C., Vaysse P.J., Forray C. Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist. Nat. Med. 2002, 8:825-830.
8. Brundin L., Bjorkqvist M., Petersen A., Traskman-Bendz L. Reduced orexin levels in the cerebrospinal fluid of suicidal patients with major depressive disorder. Eur. Neuropsychopharmacol. 2007, 17:573-579.
9. Brundin L., Bjorkqvist M., Traskman-Bendz L., Petersen A. Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt. J. Affect. Disord. 2009, 113:179-182.
10. Chabas D., Foulon C., Gonzalez J., Nasr M., Lyon-Caen O., Willer J.C., Derenne J.P., Arnulf I. Eating disorder and metabolism in narcoleptic patients. Sleep 2007, 30:1267-1273.
11. Chaki S., Funakoshi T., Hirota-Okuno S., Nishiguchi M., Shimazaki T., Iijima M., Grottick A.J., Kanuma K., Omodera K., Sekiguchi Y., Okuyama S., Tran T.A., Semple G., Thomsen W. Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists. J. Pharmacol. Exp. Ther. 2005, 313:831-839.
12. David D.J., Klemenhagen K.C., Holick K.A., Saxe M.D., Mendez I., Santarelli L., Craig D.A., Zhong H., Swanson C.J., Hegde L.G., Ping X.I., Dong D., Marzabadi M.R., Gerald C.P., Hen R. Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphen yl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocampal neurogenesis. J. Pharmacol. Exp. Ther. 2007, 321:237-248.
13. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., Fukuhara C., Battenberg E.L., Gautvik V.T., Bartlett F.S., Frankel W.N., van den Pol A.N., Bloom F.E., Gautvik K.M., Sutcliffe J.G. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 1998, 95:322-327.
14. Demet E.M., Chicz-Demet A., Fallon J.H., Sokolski K.N. Sleep deprivation therapy in depressive illness and Parkinson's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 1999, 23:753-784.
15. El Khoury A., Gruber S.H., Mork A., Mathe A.A. Adult life behavioral consequences of early maternal separation are alleviated by escitalopram treatment in a rat model of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2006, 30:535-540.
16. Feng P., Vurbic D., Wu Z., Hu Y., Strohl K.P. Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine. J. Psychopharmacol. 2008, 22:784-791.
17. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M., Sugiyama F., Yagami K., Goto K., Yanagisawa M., Sakurai T. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 2001, 30:345-354.
18. Ida T., Nakahara K., Katayama T., Murakami N., Nakazato M. Effect of lateral cerebroventricular injection of the appetite-stimulating neuropeptide, orexin and neuropeptide Y, on the various behavioral activities of rats. Brain Res. 1999, 821:526-529.
19. Ida T., Nakahara K., Murakami T., Hanada R., Nakazato M., Murakami N. Possible involvement of orexin in the stress reaction in rats. Biochem. Biophys. Res. Commun. 2000, 270:318-323.
20. Ito N., Yabe T., Gamo Y., Nagai T., Oikawa T., Yamada H., Hanawa T. I.c.v. administration of orexin-A induces an antidepressive-like effect through hippocampal cell proliferation. Neuroscience 2008, 157:720-732.
21. Jiao J., Nitzke A.M., Doukas D.G., Seiglie M.P., Dulawa S.C. Antidepressant response to chronic citalopram treatment in eight inbred mouse strains. Psychopharmacology (Berl.) 2011, 213:509-520.
22. Kishi T., Elmquist J.K. Body weight is regulated by the brain: a link between feeding and emotion. Mol. Psychiatry 2005, 10:132-146.
23. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455:894-902.
24. Krishnan V., Nestler E.J. Linking molecules to mood: new insight into the biology of depression. Am. J. Psychiatry 2010, 167:1305-1320.
25. Lutter M., Krishnan V., Russo S.J., Jung S., McClung C.A., Nestler E.J. Orexin signaling mediates the antidepressant-like effect of calorie restriction. J. Neurosci. 2008, 28:3071-3075.
26. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., Elmquist J.K. Differential expression of orexin receptors 1 and 2 in the rat brain. J. Comp. Neurol. 2001, 435:6-25.
27. Mathe A.A., Husum H., El Khoury A., Jimenez-Vasquez P., Gruber S.H., Wortwein G., Nikisch G., Baumann P., Agren H., Andersson W., Sodergren A., Angelucci F. Search for biological correlates of depression and mechanisms of action of antidepressant treatment modalities. Do neuropeptides play a role? Physiol. Behav. 2007, 92:226-231.
28. Overstreet D.H., Friedman E., Mathe A.A., Yadid G. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci. Biobehav. Rev. 2005, 29:739-759.
29. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, Orlando.
30. Petersen A., Gil J., Maat-Schieman M.L., Bjorkqvist M., Tanila H., Araujo I.M., Smith R., Popovic N., Wierup N., Norlen P., Li J.Y., Roos R.A., Sundler F., Mulder H., Brundin P. Orexin loss in Huntington's disease. Hum. Mol. Genet. 2005, 14:39-47.
31. Petersen A., Wortwein G., Gruber S.H., El-Khoury A., Mathe A.A. Nortriptyline mediates behavioral effects without affecting hippocampal cytogenesis in a genetic rat depression model. Neurosci. Lett. 2009, 451:148-151.
32. Petersen A., Wortwein G., Gruber S.H., Mathe A.A. Escitalopram reduces increased hippocampal cytogenesis in a genetic rat depression model. Neurosci. Lett. 2008, 436:305-308.
33. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
34. Pucilowski O., Overstreet D.H., Rezvani A.H., Janowsky D.S. Chronic mild stress-induced anhedonia: greater effect in a genetic rat model of depression. Physiol. Behav. 1993, 54:1215-1220.
35. Rogge G., Jones D., Hubert G.W., Lin Y., Kuhar M.J. CART peptides: regulators of body weight, reward and other functions. Nat. Rev. Neurosci. 2008, 9:747-758.
36. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., Williams S.C., Richarson J.A., Kozlowski G.P., Wilson S., Arch J.R., Buckingham R.E., Haynes A.C., Carr S.A., Annan R.S., McNulty D.E., Liu W.S., Terrett J.A., Elshourbagy N.A., Bergsma D.J., Yanagisawa M. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
37. Salomon R.M., Ripley B., Kennedy J.S., Johnson B., Schmidt D., Zeitzer J.M., Nishino S., Mignot E. Diurnal variation of cerebrospinal fluid hypocretin-1 (Orexin-A) levels in control and depressed subjects. Biol. Psychiatry 2003, 54:96-104.
38. Schuld A., Beitinger P.A., Dalal M., Geller F., Wetter T.C., Albert E.D., Hebebrand J., Pollmacher T. Increased body mass index (BMI) in male narcoleptic patients, but not in HLA-DR2-positive healthy male volunteers. Sleep Med. 2002, 3:335-339.
39. Scott M.M., Marcus J.N., Pettersen A., Birnbaum S.G., Mochizuki T., Scammell T.E., Nestler E.J., Elmquist J.K., Lutter M. Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. Behav. Brain Res. 2011, 222:289-294.
40. Suzuki M., Beuckmann C.T., Shikata K., Ogura H., Sawai T. Orexin-A (hypocretin-1) is possibly involved in generation of anxiety-like behavior. Brain Res. 2005, 1044:116-121.
41. Swaab D.F. Neuropeptides in hypothalamic neuronal disorders. Int. Rev. Cytol. 2004, 240:305-375.
42. Taheri S., Gardiner J., Hafizi S., Murphy K., Dakin C., Seal L., Small C., Ghatei M., Bloom S. Orexin A immunoreactivity and preproorexin mRNA in the brain of Zucker and WKY rats. Neuroreport 2001, 12:459-464.
43. Wang S.S., Kamphuis W., Huitinga I., Zhou J.N., Swaab D.F. Gene expression analysis in the human hypothalamus in depression by laser microdissection and real-time PCR: the presence of multiple receptor imbalances. Mol. Psychiatry 2008, 13:786-799. 741.
44. West M.J. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci. 1999, 22:51-61.
45. Wiehager S., Beiderbeck D.I., Gruber S.H., El-Khoury A., Wamsteeker J., Neumann I.D., Petersen A., Mathe A.A. Increased levels of cocaine and amphetamine regulated transcript in two animal models of depression and anxiety. Neurobiol. Dis. 2009, 34:375-380.